Andrew Hantel, MD
Andrew Hantel, MD
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, skin disorder, triple-negative breast carcinoma, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2026-08-17 | NCT07341867 |